[Brain of patients with chronic schizophrenia and neurotransmitters].
Toru
Michio
M
Tokyo Medical and Dental University.
D000818:Animals; D001923:Brain Chemistry; D002851:Chromatography, High Pressure Liquid; D002908:Chronic Disease; D005968:Glutamate Decarboxylase / Q000032:analysis; D018698:Glutamic Acid / Q000032:analysis; D006801:Humans; D018377:Neurotransmitter Agents / Q000032:analysis*; D017448:Receptors, Dopamine D2 / Q000032:analysis / Q000235:genetics; D018092:Kainic Acid Receptors / Q000032:analysis; D016194:Receptors, N-Methyl-D-Aspartate / Q000032:analysis / Q000235:genetics; D012559:Schizophrenia / Q000209:etiology* / Q000378:metabolism; D013373:Substance P / Q000032:analysis; D014446:Tyrosine 3-Monooxygenase / Q000032:analysis; D005680:gamma-Aminobutyric Acid / Q000032:analysis
D005968:Glutamate Decarboxylase; D018698:Glutamic Acid; D018377:Neurotransmitter Agents; D017448:Receptors, Dopamine D2; D018092:Kainic Acid Receptors; D016194:Receptors, N-Methyl-D-Aspartate; D013373:Substance P; D014446:Tyrosine 3-Monooxygenase; D005680:gamma-Aminobutyric Acid